The latest price target for US Physical Therapy (NYSE:USPH) was reported by Barrington Research on January 5, 2026. The analyst firm set a price target for $103.00 expecting USPH to rise to within 12 months (a possible 19.77% upside). 9 analyst firms have reported ratings in the last year.

The latest analyst rating for US Physical Therapy (NYSE:USPH) was provided by Barrington Research, and US Physical Therapy maintained their outperform rating.

The last upgrade for US Physical Therapy Inc happened on December 16, 2024 when B of A Securities raised their price target to $115. B of A Securities previously had a neutral for US Physical Therapy Inc.

The last downgrade for US Physical Therapy Inc happened on October 7, 2024 when B of A Securities changed their price target from $114 to $90 for US Physical Therapy Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of US Physical Therapy, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for US Physical Therapy was filed on January 5, 2026 so you should expect the next rating to be made available sometime around January 5, 2027.

While ratings are subjective and will change, the latest US Physical Therapy (USPH) rating was a maintained with a price target of $103.00 to $103.00. The current price US Physical Therapy (USPH) is trading at is $86.00, which is out of the analyst’s predicted range.